U.S. flag

An official website of the United States government

NM_007194.4(CHEK2):c.541C>T (p.Arg181Cys) AND Prostate cancer, somatic

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Feb 1, 2003
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000005945.6

Allele description

NM_007194.4(CHEK2):c.541C>T (p.Arg181Cys)

Gene:
CHEK2:checkpoint kinase 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
22q12.1
Genomic location:
Preferred name:
NM_007194.4(CHEK2):c.541C>T (p.Arg181Cys)
HGVS:
  • NC_000022.11:g.28725028G>A
  • NG_008150.1:g.21807C>T
  • NG_008150.2:g.21839C>T
  • NM_001005735.2:c.670C>T
  • NM_001257387.2:c.-237C>T
  • NM_001349956.2:c.445-105C>T
  • NM_007194.4:c.541C>TMANE SELECT
  • NM_145862.2:c.541C>T
  • NP_001005735.1:p.Arg224Cys
  • NP_009125.1:p.Arg181Cys
  • NP_665861.1:p.Arg181Cys
  • LRG_302t1:c.541C>T
  • LRG_302:g.21839C>T
  • LRG_302p1:p.Arg181Cys
  • NC_000022.10:g.29121016G>A
  • NM_007194.3:c.541C>T
  • O96017:p.Arg181Cys
  • p.R181C
Protein change:
R181C; ARG181CYS
Links:
UniProtKB: O96017#VAR_019104; OMIM: 604373.0008; dbSNP: rs137853010
NCBI 1000 Genomes Browser:
rs137853010
Molecular consequence:
  • NM_001257387.2:c.-237C>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001349956.2:c.445-105C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001005735.2:c.670C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_007194.4:c.541C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_145862.2:c.541C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Prostate cancer, somatic
Identifiers:
MedGen: C4015779

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000026127OMIM
no assertion criteria provided
Pathogenic
(Feb 1, 2003)
somaticliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedsomaticnot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Mutations in CHEK2 associated with prostate cancer risk.

Dong X, Wang L, Taniguchi K, Wang X, Cunningham JM, McDonnell SK, Qian C, Marks AF, Slager SL, Peterson BJ, Smith DI, Cheville JC, Blute ML, Jacobsen SJ, Schaid DJ, Tindall DJ, Thibodeau SN, Liu W.

Am J Hum Genet. 2003 Feb;72(2):270-80. Epub 2003 Jan 17.

PubMed [citation]
PMID:
12533788
PMCID:
PMC379222

Details of each submission

From OMIM, SCV000026127.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In 1 of 178 prostate cancer (176807) tumor samples, Dong et al. (2003) found a 541C-T transition in exon 3 of the CHEK2 gene predicted to result in an arg181-to-cys (R181C) mutation. The mutation was not found in any of 298 men with familial prostate cancer, 400 men with sporadic prostate cancer, or 423 unaffected men.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1somaticnot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 18, 2022